interstitial lung disease

Primary Care Can Address Complex Lung Diseases, Too

by

Primary care physicians (PCPs) often face challenges in diagnosing complex pulmonary issues in patients, particularly when nonspecific symptoms appear similar to cardiovascular issues, asthma, or chronic obstructive pulmonary disease. However, clinicians can cover both pulmonary and cardiovascular concerns during an exam, potentially shortening delays in the diagnosis of interstitial lung diseases (ILDs), including pulmonary fibrosis … Read more

Sorry Fido, The eNose Can Smell ILD Subtypes Too

by

SAN FRANCISCO — Dogs trained to sniff out lung disease may need to look for another line of work if an “electronic nose” sensor in development makes it into widespread clinical practice. In a multicenter cohort study of 589 patients with a diagnosis of interstitial lung disease (ILD) by multidisciplinary team discussion and evidence of … Read more

Diet, Nutrition, and Effects on Lung Health and Disorders

by

Primary care providers are accustomed to talking with their patients about how diet and nutrition influence health conditions like diabetes and cardiovascular health. But their effect on lung health? “It’s not always at the forefront of our recommendations for lung health,” said Christina M. Eckhardt, MD, MS, a pulmonologist and assistant professor of medicine and … Read more

Advancing pulmonary fibrosis treatment through targeted drug delivery

by

Announcing a new article publication for BIO Integration journal. Pulmonary fibrosis (PF) is a progressive interstitial lung disease characterized by excessive extracellular matrix deposition and tissue scarring, and leading to impaired lung function and respiratory failure. Although current treatments, such as pirfenidone and nintedanib, slow disease progression, they fail to completely halt or reverse fibrosis … Read more

Breakthrough protein offers new hope for pulmonary sarcoidosis treatment

by

Pulmonary sarcoidosis is a lung disease characterized by granulomas-tiny clumps of immune cells that form in response to inflammation. It’s the most inflammatory of the interstitial lung diseases (ILDs), a family of conditions that all involve some level of inflammation and fibrosis, or scarring, of the lungs. In the U.S., pulmonary sarcoidosis affects around 200,000 … Read more

Blood Test Unveils Disease Course in Systemic Sclerosis

by

TOPLINE: Type I interferon (IFN) score may effectively predict disease progression in limited cutaneous systemic sclerosis (lcSSc), with patients having a high IFN activity presenting worse clinical outcomes. METHODOLOGY: Researchers conducted a longitudinal retrospective analysis to investigate whether the serum IFN score could predict clinically meaningful progression in patients with lcSSc using a novel composite … Read more